| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 10 |
| 1 | DEXAMETHASONE 1.5 MG | 10 |
| 2 | PANTOPRAZOLE | 9 |
| 3 | ALLOPURINOL | 8 |
| 4 | BISOPROLOL FUMARATE | 8 |
| 5 | CYCLOPHOSPHAMIDE | 8 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 8 | CYTARABINE | 8 |
| 9 | FOLIC ACID | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 1 | INOTUZUMAB OZOGAMICIN | 5 | 0.0017 |
| 2 | PONATINIB HYDROCHLORIDE | 8 | 0.0015 |
| 3 | BLINATUMOMAB | 6 | 0.0006 |
| 4 | LOXAPINE | 1 | 0.0003 |
| 5 | TORSEMIDE | 8 | 0.0002 |
| 6 | INSULIN GLARGINE-YFGN | 5 | 0.0002 |
| 7 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 6 | 0.0002 |
| 8 | LACTULOSE | 8 | 0.0002 |
| 9 | ELOSULFASE ALFA | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 11 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 10 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 9 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 9 |
| 4 | Osmotic Laxative [EPC] | 9 |
| 5 | Aldosterone Antagonist [EPC] | 8 |
| 6 | Alkylating Drug [EPC] | 8 |
| 7 | Loop Diuretic [EPC] | 8 |
| 8 | Vitamin B12 [EPC] | 8 |
| 9 | Vitamin C [EPC] | 8 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 5 | 0.0017 |
| 1 | CD19-directed Cytolytic Antibody [EPC] | 1 | 0.0012 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 3 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 5 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 6 | Aldosterone Antagonist [EPC] | 8 | 0.0001 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 8 | 0.0000 |
| 8 | Anti-IgE [EPC] | 4 | 0.0000 |
| 9 | Bile Acid [EPC] | 1 | 0.0000 |